ZIOPHARM Oncology Inc. (ZIOP) has fallen Monday morning, with the stock losing -5.19% in pre-market trading to 1.28. ZIOP's short-term technical score of 66 indicates that the stock has traded more bullishly over the last month than 66% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, the stock ranks higher than 88% of stocks. ZIOPHARM Oncology Inc. has fallen 5.59% over the past month, closing at $1.38 on November 22. During this period of time, the stock fell as low as $1.18 and as high as $1.45. ZIOP has an average analyst recommendation of Buy. The company has an average price target of $3.17.
ZIOP has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on ZIOP!